In mycobacteria, the ketoacyl-acyl carrier protein (ACP) reductase MabA (designated FabG in other bacteria) catalyzes the NADPH-dependent reduction of -ketoacyl-ACP substrates to -hydroxyacyl-ACP products. This first reductive step in the fatty-acid biosynthesis elongation cycle is essential for bacteria, which makes MabA/FabG an interesting drug target. To date, however, very few molecules targeting FabG have been discovered and MabA remains the only enzyme of the mycobacterial type II fatty-acid synthase that lacks specific inhibitors. Despite the existence of several MabA/FabG crystal structures, the structural rearrangement that occurs upon cofactor binding is still not fully understood. Therefore, unlocking this knowledge gap could help in the design of new inhibitors. Here, high-resolution crystal structures of MabA from Mycobacterium smegmatis in its apo, NADP + -bound and NADPH-bound forms are reported. Comparison of these crystal structures reveals the structural reorganization of the lid region covering the active site of the enzyme. The crystal structure of the apo form revealed numerous residues that trigger steric hindrance to the binding of NADPH and substrate. Upon NADPH binding, these residues are pushed away from the active site, allowing the enzyme to adopt an open conformation. The transition from an NADPH-bound to an NADP + -bound form is likely to facilitate release of the product. These results may be useful for subsequent rational drug design and/or for in silico drugscreening approaches targeting MabA/FabG. research papers Acta Cryst. (2018). D74, 383-393 Kü ssau et al. -Keto-acyl-ACP reductase 385 research papers Acta Cryst. (2018). D74, 383-393 Kü ssau et al. -Keto-acyl-ACP reductase 393
Introduction
Mycobacterium tuberculosis (Mtb), the aetiological agent of tuberculosis (TB), is one of the deadliest human pathogens and is responsible for about 10.5 million new infections and 1.4 million deaths annually (World Health Organization, 2016) . This high rate of mortality, despite existing chemotherapy, is owing to the lack of an efficient vaccine, co-infection with HIV and the emergence of multidrug-resistant, extensively drugresistant and, more recently, totally drug-resistant strains of Mtb that considerably limit treatment options. Therefore, the development of new therapies, including new anti-TB drugs, is needed more than ever. The high impermeability of the mycobacterial cell wall, however, represents a serious obstacle to the identification of active compounds. The hydrophobicity of the mycomembrane is essentially caused by the presence of mycolic acids, consisting of very long -alkyl, -hydroxy fatty acids, comprising up to 90 C atoms (Pawełczyk & Kremer, ISSN 2059-7983 # 2018 International Union of Crystallography 2014). The complex machinery responsible for mycolic acid biosynthesis involves numerous enzymes, some of which are the target of important antitubercular drugs, while others represent potent pharmacological targets that require further exploitation (Qué mard, 2016) .
The biosynthesis of mycolic acids is driven by two distinct elongation systems: the so-called type I and type II fatty-acid synthases (FAS I and FAS II, respectively; Bhatt, Molle et al., 2007; Qué mard, 2016; Pawełczyk & Kremer, 2014) . FAS I consists of a single polypeptide, resembling the eukaryotic FAS (Boehringer et al., 2013) , which possesses all of the catalytic domains for the de novo synthesis of fatty acids and shows a bimodal activity that leads to the production of palmitic acid (C 16 ) and hexacosanoic acid (C 26 ), also referred to as the -branch. In contrast to FAS I, FAS II is composed of multiple enzymes with discrete functions that interact to further elongate the C 16 precursor generated by FAS I to produce meromycolic acids containing up to 56 C atoms. Meromycolates can be functionalized by the introduction of chemical modifications, which is performed by a diverse family of SAM-dependent methyltransferases. Following functionalization, meromycolates are condensed together with the -branch by the polyketide synthase Pks13 to produce mycolic acids. Like the FAS II complexes found in other prokaryotes or in plants, the mycobacterial FAS II system involves four distinct enzymes that work successively and in an iterative manner to catalyze the elongation step of the meromycolic acid. In Mtb this process is initiated by MabA (Rv1483; designated FabG in other bacteria), a -ketoacyl-acyl carrier protein (ACP) reductase that catalyzes the conversion of -ketoacyl-ACP to -hydroxyacyl-ACP (Marrakchi et al., 2002; Banerjee et al., 1998) , which is subsequently converted by the heterodimeric (3R)-hydroxyacyl-ACP dehydratases HadAB and HadBC (Rv0635-Rv0637) to trans-2-enoyl-ACP (Sacco et al., 2007) . InhA (Rv1484), a trans-2-enoyl-ACP reductase, converts trans-2-enoyl-ACP to saturated acyl-ACP products (Qué mard et al., 1995; Banerjee et al., 1994) . Finally, the -ketoacyl ACP synthases KasA (Rv2245) and KasB (Rv2246) elongate the acyl-ACP substrates by two additional C atoms to generate -ketoacyl ACP fatty acids (Kremer et al., 2002; Bhatt et al., 2005; Bhatt, Fujiwara et al., 2007) , which are again reduced by MabA when entering a second round of the cycle. After each reductive cycle, the growing fatty-acyl chain is elongated by two additional C atoms. All four enzymes have been shown to be essential for mycobacterial viability, thereby representing potent drug targets. Isoniazid, the cornerstone of TB therapy, inhibits InhA, whereas thioacetazone and isoxyl, which were formerly used for TB treatment, inhibit the HadAB/BC complexes Coxon et al., 2013; Grzegorzewicz et al., 2012 Grzegorzewicz et al., , 2015 . Several chemical entities such as thiolactomycin or indazole sulfonamide have been shown to inhibit KasA (Kapilashrami et al., 2013; Kremer et al., 2000; Abrahams et al., 2016) . However, no specific inhibitor of MabA has been reported.
FabG/MabA belongs to the short-chain dehydrogenases/ reductase (SDR) superfamily, characterized by the presence of a central Rossmann fold and the use of NADH or NADPH as a cofactor. SDR proteins have been shown to undergo structural rearrangements upon binding of the cofactor. Based on high-resolution crystal structures of the apo and holo forms of Mtb MabA (MabA Mtb ), it was proposed that similar structural rearrangements are likely to occur in this protein (Cohen-Gonsaud et al., 2002 . However, our understanding of this mechanism still remains obscured by the fact that parts of the structure could not be modelled in the apo structure of MabA, while in the MabA-NADP + complex the nicotinamide group of the cofactor could not be modelled as it was not visible in the electron density. The difficulty in visualizing the flexible region covering the active site in the crystal structures of the SDR protein family, and in particular in FabG proteins, remains a recurrent issue. Recently, this region was built in the apo form of Vibrio cholerae FabG (Hou et al., 2015) . The complete apo and holo structures of Pseudomonas aeruginosa FabG have also been described, revealing a reduced mobility of this flexible region when the cofactor was bound (Cukier et al., 2013) . We have also shown that in the MabA-like protein MSMEG_6753 from M. smegmatis, a nonpathogenic mycobacterial species, the same region was very dynamic and the binding of NADP + was associated with important structural changes (Blaise et al., 2017) . Together, these two studies suggest that upon binding of the cofactor the so-called flexible loop might adopt a closed conformation.
Considering the potential of MabA as an attractive drug target, a thorough comparison of the complete apo and holo crystal structures would be particularly helpful for subsequent target-based drug-discovery approaches as well as for the design of specific inhibitors and structure-activity relationship studies. Here, we investigated the structural dynamics that occur upon the binding of cofactor by M. smegmatis MabA (MabA MSMEG ).
Materials and methods

Cloning, protein expression and purification
The mabA MSMEG (MSMEG_3150) gene was cloned into pET-30 Ek/LIC as described previously (Blaise et al., 2017) . The protein was expressed in Escherichia coli BL21 Rosetta 2 (DE3) pLysS cells (Novagen). Transformants were grown at 37 C and protein expression was induced with 1 mM isopropyl -d-1-thiogalactopyranoside during exponential growth for 3 h. The cells were harvested by centrifugation at 6000g for 15 min, resuspended in lysis buffer (50 mM Tris-HCl pH 8, 400 mM NaCl, 5 mM -mercaptoethanol, 1 mM benzamidine) and disrupted by sonication. The cell debris was centrifuged at 30 000g for 45 min and the supernatant was loaded by gravity onto nickel Sepharose beads (IMAC). A first wash step was performed using lysis buffer and a second wash used a buffer consisting of 50 mM Tris-HCl pH 8, 1 M NaCl, 5 mM -mercaptoethanol. Proteins were eluted with 50 mM Tris-HCl pH 8, 400 mM NaCl, 5 mM -mercaptoethanol, 250 mM imidazole. The eluted proteins were then dialyzed at 4 C overnight against 50 mM Tris-HCl pH 8, 200 mM NaCl, 5 mM research papers -mercaptoethanol. To cleave the N-terminal tags, recombinant His-tagged Tobacco etch virus (TEV) protease was added to the protein solution at a ratio of 1 mg protease to 50 mg eluted protein. The proper removal of the N-terminal tags was assessed by Western blotting using anti-His and anti-S-tag primary antibodies. The tag-less proteins were then loaded onto an IMAC column pre-equilibrated with dialysis buffer. MabA MSMEG was collected in the flowthrough and concentrated to 5 mg ml À1 . The final purification step was performed on an ENrich SEC 650 size-exclusion chromatography column (Bio-Rad), which was eluted with 50 mM Tris-HCl pH 8, 200 mM NaCl, 5 mM -mercaptoethanol. The purity of the protein was estimated to be 95% by Coomassie Blue-stained SDS-PAGE. Proteins obtained from these three chromatographic steps were used for determination of the kinetic constants as well as for crystallization experiments using the apo and NADPH-bound forms. The NADP + -bound crystals were obtained using MabA MSMEG possessing its N-terminal tags and purified after a single step of IMAC followed by dialysis.
Enzymatic assays
NADPH and acetoacetyl-CoA were purchased from Sigma-Aldrich. The reductase activity was determined by monitoring the decrease in the optical density at 340 nm corresponding to the oxidation of NADPH to NADP + . Kinetic constants for NADPH, acetoacetyl-CoA and -keto-octanoyl-CoA were determined with a fixed concentration of one component (1 mM for NADPH and 2 mM for acetoacetyl-CoA) and a range of concentrations of the second substrate. Assays were performed in a volume of 20 ml to determine the kinetic constants for acetoacetyl-CoA and -keto-octanoyl-CoA or in 80 ml for NADPH. Reaction mixtures consisted of 50 mM potassium phosphate buffer pH 7.0, the concentrations of substrates stated above and between 0.25 and 0.1 mM MabA MSMEG . The enzymatic reactions were initiated by the addition of acetoacetyl-CoA after incubation for 5 min at 25 C. The oxidation of NADPH was followed by removing 1.5 ml aliquots of the reaction mixture for analysis in a NanoDrop 2000c spectrophotometer (path length 1 mm; Thermo Scientific) to determine the kinetic constants of the -ketoacyl-CoAs and by continuous reading in an 80 ml quartz cuvette to determine the K m for NADPH in a NanoDrop 2000c spectrophotometer (path length 10 mm; Thermo Scientific). Experiments were performed in triplicate. Data were fitted using nonlinear least-squares regression with GraphPad Prism.
Determination of molecular weight by size-exclusion chromatography
The oligomeric state of MabA MSMEG in solution was assessed on an ENrich SEC 650 gel-filtration column (Bio-Rad) eluted with 50 mM Tris-HCl pH 8, 200 mM NaCl, 5 mM -mercaptoethanol at a flow rate of 0.5 ml min À1 at 4 C. Different concentrations of protein were assessed. The molecular weight was determined based on a calibration curve obtained using the Gel Filtration Markers Kit for Protein Molecular Weights 12 400-200 000 Da (Sigma-Aldrich) and dextran blue to assess the column void volume. The apparent mass was obtained by plotting the partition coefficient K av against the logarithms of the molecular weights of standard proteins.
Crystallization
The apo MabA MSMEG crystals were grown in sitting drops in MR Crystallization Plates (Hampton Research) at 18 C by mixing 1.5 ml protein solution concentrated to 6 mg ml À1 with 1.5 ml reservoir solution consisting of 100 mM bis-tris propane pH 7, 2.7 M ammonium sulfate, 5% dimethylsulfoxide (DMSO) and using the microseeding technique. These crystals were briefly soaked in 100 mM bis-tris propane pH 7, 2.7 M ammonium sulfate, 5% DMSO, 20% glycerol prior to cryocooling in liquid nitrogen. The MabA MSMEG -NADP + complex was co-crystallized at 7.7 mg ml À1 in the presence of 5 mM NADP + by mixing 0.8 ml protein solution with 0.8 ml reservoir solution consisting of 100 mM sodium citrate pH 5.6, 1.0 M lithium sulfate, 0.5 M ammonium sulfate. The MabA MSMEG -NADPH crystals were obtained by mixing 0.8 ml protein solution concentrated to 7.5 mg ml À1 and containing 5 mM NADPH with 0.8 ml reservoir solution consisting of 0.1 M bistris pH 5.5, 0.2 M NaCl, 25% PEG 3350. All crystallization conditions for these complexes were obtained in sitting drops in 96-well SWISSCI MRC plates (Molecular Dimensions) at 18 C. Crystals obtained in the presence of cofactors were cryocooled without any additional cryoprotection.
Data collection, structure determination and refinement
The apo MabA MSMEG and MabA MSMEG -NADP + data sets were collected on the ID30B and ID23-2 beamlines, respectively, at the European Synchrotron Radiation Facility (ESRF), Grenoble, France. The MabA MSMEG -NADPH data set was collected on the X06DA-PXIII beamline at the Swiss Light Source (SLS), Villigen, Switzerland. Data were processed with XDS and scaled and merged with XSCALE (Kabsch, 2010) . As the crystal used to collect the MabA MSMEG -NADPH data set was not cryoprotected, the ice-ring zones were excluded during data processing, which explains the relative low completeness of this data set. The MabA MSMEG -NADP + structure was solved by molecular replacement using the structure of MabA Mtb as a model (PDB entry 1uzn; Cohen-Gonsaud et al., 2002) 
Synthesis of b-keto-octanoyl-CoA
The synthesis of -keto-octanoyl-CoA was adapted from Kanchanabanca et al. (2013) and is described in the Supporting Information.
Results and discussion
Biochemical properties of MabA MSMEG
Because FabG proteins can be found either as homodimers or homotetramers in solution, we determined the oligomeric state of MabA MSMEG by size-exclusion chromatography (Hou et al., 2015; Marrakchi et al., 2002) . The elution peak at 12.9 ml for MabA MSMEG lacking the N-terminal tags corresponds to an apparent molecular weight of 87 kDa, which corresponds to a molecular weight between those of a homotrimer (theoretical molecular weight 79 kDa) and a homotetramer (theoretical molecular weight 106 kDa) ( Fig. 1a ). No change in the oligomeric state was observed on decreasing the protein concentration (data not shown). Because we also report the crystal structure of MabA MSMEG with the N-terminal tags (in the NADP + -bound structure), we also determined the oligomeric state of this protein in solution (Fig. 1b ). This tagged form eluted at 12.6 ml, correlating with an estimated mass of 133 kDa, supporting a homotetrameric protein (the predicted molecular weight is 129 kDa). Taken collectively, these results are consistent with a homotetrameric form of MabA MSMEG in solution, which was further confirmed by analysis of the crystal packing of the different crystal forms obtained.
To check whether the purified protein was catalytically active, we next determined the steady-state kinetic properties of MabA MSMEG . The sigmoidal nature of the plot of the velocity versus the NADPH concentration, while keeping the acetoacetyl-CoA (AcAcCoA) concentration constant, attests to the allosteric behaviour (Hill coefficient of 1.7 AE 0.25) of MabA MSMEG (Fig. 1c) . In contrast, no significant cooperativity was observed when the concentration of NADPH was kept constant and the concentration of AcAcCoA (Fig. 1d) or -keto-octanoyl-CoA (C 8 -CoA; Fig. 1e ) was increased. MabA MSMEG exhibits a K m of 3.5 AE 0.42 mM and a k cat of 1.14 s À1 for AcAcCoA. The enzyme has a higher affinity for C 8 -CoA, with a K m of 0.6 AE 0.12 mM and a faster catalytic cycle (k cat = 5.72 s À1 ). According to the values of the catalytic efficiency k cat /K m , MabA MSMEG has a preference for longer substrates, as it is 30 times more efficient at catalyzing the NADPH-dependent reduction of C 8 -CoA than that of AcAcCoA. The catalytic efficiencies are in agreement with the previously reported kinetic constants of Mab Mtb (Marrakchi et al., 2002) . Moreover, it has also been shown that MabA Mtb presents allosteric behaviour (Silva et al., 2008) . Allosteric behaviour and positive cooperativity for NADPH have also been reported for the FabG enyzmes from Staphylococcus aureus and V. cholerae (Dutta et al., 2012; Hou et al., 2015) .
Crystal structure of apo MabA MSMEG
The apo MabA MSMEG structure was solved by molecular replacement as described in x2 and was refined to 1.7 Å resolution ( Table 1 ). The asymmetric unit contained two monomers ( Fig. 2a) PISA server (Krissinel & Henrick, 2007) predicts the formation of a stable homotetramer, corroborating the results of size-exclusion chromatography (Figs. 1a and 1b ) and the quaternary structure of MabA Mtb (Cohen-Gonsaud et al., 2002) . All residues from Gly17 to His255 could be traced in both chains. The first 16 residues plus one glycine residue from the TEV protease cleavage site were not visible. Of note, an extra, but non-interpretable electron-density map in proximity to Arg107 in chain A (data not shown) could be seen but did not correspond to any component of the crystallization condition. Additionally, seven sulfate molecules were placed.
In each monomer, one sulfate ion is sequestered by the Arg33, Arg55 and Ser57 side chains and occupies a position similar to that of the NADPH 2 0 -phosphate group in the adenosine ribose binding site (Fig. 2b) . A similar occupancy of sulfate was described in the crystal structure of the apo form of the Plasmodium falciparum FabG protein (Wickramasinghe et al., 2006) .
The overall structure adopts a Rossmann fold, with a central -sheet made up of seven parallel -strands surrounded by -helices, as typically seen in the SDR superfamily (Kavanagh et al., 2008) . The region comprising residues 195-217 between strand 6 and helix 6, which is named the flexible region and is disordered in most apo FabG structures, could be traced (Fig. 2c) . Additionally, residues 98-107 and 150-157 near the catalytic triad that are absent in the apo MabA Mtb structure (PDB entry 1uzm; Cohen-Gonsaud et al., 2002) could be modelled. Since MabA MSMEG and MabA Mtb share 83% primary-sequence identity, it is not surprising that the apo MabA MSMEG and apo MabA Mtb structures are very similar, with a root-mean-square deviation (r.m.s.d.) of 0.92 Å over 212 C residues. Nonetheless, differences were noticed in the region 195-217 (187-209 in MabA Mtb ) located between strand 6 and helix 6, with the residues adopting different secondary structures (Fig. 2d ). In the apo MabA MSMEG structure residues 195-197 adopt a 3 10 -helix followed by a coil, The elution profile of the proteins used for calibration is displayed as a black line and the elution profile of MabA MSMEG is shown in blue. Calibration was established using -amylase (1; 200 kDa), bovine serum albumin (2; 66 kDa), carbonic anhydrase (3; 29 kDa) and cytochrome c (4; 12.4 kDa), which eluted with estimated volumes of 11.6, 13.2, 15 and 15.8 ml, respectively. The void volume was estimated at 8.8 ml using dextran blue. MabA MSMEG was concentrated to 5 mg ml À1 . The MabA MSMEG elution peak at 12.90 ml corresponds to a calculated molecular weight of 87 kDa. (b) Oligomeric state of MabA MSMEG with its N-terminal tags determined by size-exclusion chromatography. The elution profile of the proteins used for calibration is displayed as a black line and the elution profile of MabA MSMEG is shown in blue. Calibration was established using -amylase (1; 200 kDa), alcohol dehydrogenase (2; 150 kDa), bovine serum albumin (3; 66 kDa), carbonic anhydrase (4; 29 kDa) and cytochrome c (5; 12.4 kDa), which eluted with estimated volumes of 11.9, 12.6, 13.4, 15.2 and 16.1 ml, respectively. The void volume was estimated at 8.9 ml using dextran blue. The MabA MSMEG elution peak at 12.6 ml corresponds to a calculated molecular weight of 133 kDa. Steady-state kinetic properties of MabA MSMEG for (c) NADPH (with a fixed concentration of AcAcCoA), (d) acetoacetyl-CoA and (e) -keto-octanoyl-CoA. Error bars indicate the standard error.
while residues 200-208 form an -helix that is then followed by another 3 10 -helix (residues 209-213). However, in the apo MabA Mtb structure two -helices comprising residues 187-193 and 196-205 are formed .
Surprisingly, no shift of the catalytic triad was observed, in contrast to that previously seen in the apo form of MabA Mtb (PDB entry 1uzm) . The catalytic triad Ser148, Lys165 and Tyr161 in MabA MSMEG is already positioned in an active conformation, as found in the FabG-NADP + structure from E. coli (Price et al., 2004;  Fig. 2e ). Such an active-site conformation in the absence of any cofactor is not unique and has already been reported in the apo structures of FabG from V. cholerae (PDB entry 3rro; Hou et al., 2015) and the FabGlike protein MSMEG_6753 from M. smegmatis (PDB entry 5t2v; Blaise et al., 2017) .
As there is no complete structure of MabA Mtb bound to cofactor available and since the cofactor could only be partially modelled in the MabA Mtb -NADP + complex (Cohen-Gonsaud et al., 2005) , we also crystallized both NADPHbound and NADP + -bound forms of MabA MSMEG . This not only helped to identify all of the residues involved in cofactor recognition, but also provided new insights into the dynamics of the flexible 195-217 region.
Crystal structures of MabA MSMEG complexed with NADP + and NADPH
The crystal structure of the MabA MSMEG -NADP + complex could be solved and refined to 2.4 Å resolution ( Table 1) . The asymmetric unit contained the biological tetramer of MabA MSMEG (Fig. 3a) . Electron density for the four NADP + cofactors is well defined in all the monomers and the cofactors could therefore be entirely modelled (Fig. 3b ). Rebuilding was near to completion only for chain A, where we were able to model residues 15-255 ( Fig. 3c) , while in chains B, C and D residues 197-208, 197-202 and 197-209 , respectively, could not be modelled. Importantly, all of the amino acids involved in cofactor binding are seen in chain A, allowing a detailed interaction map with NADP + to be built (Fig. 3d ). NADP + is tightly bound by its nicotinamide group to the side chain of Arg205 and the main chains of Gly192 and Ile194, while Pro191 interacts by hydrophobic interaction. The side chains research papers Acta Cryst. Crystal structure of MabA MSMEG bound to NADP + (a) The overall structure is represented as a cartoon, the location of the flexible loop between helix of Tyr161 and Lys165 are in contact with O2 of the ribose. The pyrophosphate group of NADP + binds the main chains of Ile35 and Gly36 as well as the side chain of Arg33. The ribose of the adenosine interacts with the main chain of Gly98 and the side chain of Asn32. The latter also contacts the phosphate group of adenosine. The adenine group is bound by the side chain of Thr119 via a water molecule, and also by the side chain of Asp69 and the main chain of Val70. The phosphate group of adenosine is also involved in salt bridges to the guanidinium groups of Arg33 and Arg55.
Moreover, we also solved the co-crystal structure of MabA MSMEG bound to NADPH (Table 1 ). The asymmetric unit consists of four monomers that all enclose an NADPH molecule. The monomers present disordered regions. Only one monomer, chain A, is almost complete: residues 14-255 could be traced including the flexible region 195-217 (Fig. 4a) . In chains B, C and D, in addition to the N-terminal part that is also missing in chain A, residues 197-209, 196-210 and 199-210 , respectively, from the flexible region were not visible in the electron-density map. Furthermore, although it is clear from the simulated-annealing OMIT map that all of the subunits are occupied by NADPH, only the NADPH in chain B could be entirely traced (Fig. 4b) . As chain A was almost completely rebuilt but with partial NADPH occupancy, and as full NADPH occupancy was observed in chain B, we could map the NADPH-binding site by reporting the interactions that occur in these two subunits ( Figs. 4c and 4d) . As a similar positioning of NADPH and NADP + is observed, the residues contacting NADP + also contact NADPH. Additional residues involved in cofactor binding could be identified, notably Ser100 that contacts the ribose. Despite the relatively well conserved interaction network in the two cofactor-bound structures, a significant structural change was discerned. The side chain of Arg205 that was involved in recognition of the nicotinamide group of NADP + appears too far away to contact the NADPH cofactor ( Figs. 4c and 4d ). This structural rearrangement is triggered by a change in the positioning of the flexible region.
Cofactor binding-induced structural rearrangements
The structures of the apo, NADPH-bound and NADP +bound forms of MabA MSMEG are similar overall. Superposition of the NADP + -bound and NADPH-bound structures with the apo form generates an r.m.s.d. of 0.64 Å over 232 and 229 C atoms, respectively, while the MabA MSMEG -NADPH and MabA MSMEG -NADP + structures are slightly more distant, with an r.m.s.d. of 1.05 Å over 234 C atoms. The main structural difference remains in the different conformations of residues 195-215. The holo MabA MSMEG structures appear in a more open state than the apoform structure. These different conformations are mainly triggered by residues 195-215, which display large movements and undergo a secondary-structure reorganization (Fig. 5a ). In the MabA Mtb structure, NADP + also seems to induce a structural change since the flexible region is more ordered in the NADP +bound form than in the apo form (Cohen-Gonsaud et al., 2002 .
To address whether and how these structural changes influence substrate binding, a C 16 fatty-acid molecule was modelled into the MabA MSMEG active site by superposition of our structures with the crystal structure of InhA bound to trans-2-hexadecenoyl-(N-acetylcysteamine)-thioester and NADH (PDB entry 1bvr; Rozwarski et al., 1999) . The proper positioning of the catalytic triad in apo MabA MSMEG (Fig. 2e) is however not compatible with binding of the cofactor because of the presence of the Glu197 side chain that provides steric hindrance of the pyrophosphate group of NADPH. Docking with the fatty acid shows that numerous residues in the apo form of MabA MSMEG would trigger clashes with the lipid. The side chains of Arg205, Leu202 and Ile99 substantially block the lipid-binding pocket (Fig. 5b) . In contrast, in the NADPHbound structure, both the lipid-and the NADPH-binding cavities are accessible owing to the shift of the side chain of Ile99. Since the side chains of Arg205 and Leu202 are pushed away from the lipid cavity and because the side chain of Glu197 no longer interferes with the pyrophosphate group of NADPH, accommodation of the cofactor in its binding pocket is possible (Fig. 5c ). In this conformation, residues 197-201 and 204-213 form two -helices (Fig. 5a, middle panel) , whereas they form 3 10 -helices and one shorter -helix in the apo form (Fig. 5a, left panel) .
The active site of the NADP + -bound form appears much more accessible as some of the residues move more than 10 Å away from their positions in the apo form. The flexible region adopts different secondary structures compared with the structures of the apo or NADPH-bound forms. Residues 195-203 now form a loop, while residues 204-208 form an -helix that appears to be much shorter than in the NADPH-bound and apo forms (Fig. 5a, right panel) . This helix is moved towards the substrate-binding site, which positions the Arg205 side chain below the lipid and allows its interaction with the nicotinamide group of the cofactor (Fig. 5d ).
Comparison of these three structures allows sequential structural rearrangements to be proposed, in which the apo MabA MSMEG would initially be in a closed state. The flexible loop would then open to bind NADPH and the lipid (a -ketoacyl-ACP) and after catalysis adopts an even more open state to release the product (a -hydroxyacyl-ACP) as well as the oxidized cofactor. This scenario is in agreement with the kinetic analysis performed on MabA Mtb , where the authors proposed a sequential binding order for the cofactor and the substrate (Silva et al., 2008) . The important changes observed between the NADPH-bound and NADP + -bound structures are surprising as the two molecules only differ by one H atom, but are consistent with other FabG crystal structures. In the S. aureus FabG structure bound to NADPH (PDB entry 3sj7; Dutta et al., 2012) the position of the flexible region is similar to our observation, while in the Listeria monocytogenes FabG structure bound to NADP + (PDB entry 4jro; Center for Structural Genomics of Infectious Diseases, unpublished work) this region displays a more open conformation ( Figs. 6a and 6b ). Nevertheless, the movements observed when comparing the three structures of MabA MSMEG seem to differ from those of other FabG proteins, as described for instance for the P. aeruginosa FabG structures (Cukier et al., 2013) . Indeed, NADPH binding induced a transition from a low-ordered to a higher ordered loop and an inward movement of this loop, albeit moderate, towards the cofactor-binding site (Fig. 6c ). In MabA MSMEG binding of the cofactors leads to a reordering of the flexible loop with secondarystructure rearrangements, but in contrast to P. aeruginosa FabG an outward movement of the loop is observed (Fig. 6d ). The reason for these mechanistic differences may be explained by the fact that MabA can bind to much larger substrates, namely the meromycolic acids, while FabG from other bacterial species binds to much smaller acyl chains. The catalytic domain of MabA may require a more open form than conventional FabG proteins to accommodate/release its very bulky substrates and products.
Conclusion
Potent inhibitors of the P. aeruginosa FabG enzyme have recently been identified, emphasizing the interest in developing specific inhibitors of this essential class of enzymes (Cukier et al., 2013) . Despite being excellent antimicrobial targets owing to their crucial role in mycolic acid biosynthesis, to the best of our knowledge no specific inhibitors have yet been reported for mycobacterial MabA proteins. In this study, we provide a sequential and dynamic mechanism that comprises important structural rearrangements that occur during catalysis by MabA. This dynamic primarily involves a continuum of changes within a flexible region ranging from a closed to an open conformation. Access to these structural details will be very informative for subsequent in silico drugscreening approaches and structure-activity relationship studies, as well as for the design of optimal and effective inhibitors of Mtb and other pathogenic mycobacteria.
